(Doctorate in Biomedical Science, Faculty of Medicine, Universitas Sriwijaya, Sumatera Selatan, Indonesia)
(2) Krisna Murti
(Department of Anatomical Pathology, Faculty of Medicine, Universitas Sriwijaya/Mohammad Hoesin Hospital Palembang, Indonesia)(3) Erry Gumilar Dachlan
(Department of Obstetrics and Gynecology, Faculty of Medicine, Universitas Airlangga/Dr. Soetomo Regional Hospital Surabaya, Indonesia)(4) Iche Andriyani Liberty
(Department of Epidemiology and Biostatistics, Faculty of Public Health, Universitas Sriwijaya, Sumatera Selatan, Indonesia)(5) Rozi Aditya Aryananda
(Department of Obstetrics and Gynecology, Faculty of Medicine, Universitas Airlangga/Dr. Soetomo Regional Hospital Surabaya, Indonesia)*Corresponding author
AbstractPlacenta accreta spectrum results in significant morbidities. Implantation process is regulated by PGE2 among other factors. This review aimed to discuss the role of PGE2 in the placenta accreta spectrum. Review of literatures searched in PubMed, PubMedCentral, EuropePMC, Wiley, and Science Direct with relevant keywords. Articles found were screened by authors and voted for inclusion. PGE2 is synthesized from arachidonic acid by COX. Increased synthesis of PGE2 results in increased angiogenesis and placental invasion. PGE2 action mainly occurs through the EP1-EP4 as the main receptors of PGE2. Reduced PGE2 receptors expression may results in defective decidualization resulting in poor pregnancy outcomes. Inactivation of PGE2 occurs through HPGD enzyme. Upregulation of HPGD results in lower PGE2 tissue concentration leading to decreased PGE2 activity. Disorders of HPGD expression has been implicated in abnormal implantation in animals. PGE2 synthesis, signaling, and inactivation plays significant role in placental invasion. Defects in any of the processes may lead into placenta accreta spectrum.
KeywordsProstaglandin E2; Prostaglandin Receptor; Hydroxyprostaglandin Dehydrogenase; Placenta Accreta Spectrum
|
DOIhttps://doi.org/10.33122/ejeset.v7i1.1445 |
Article metricsAbstract views : 0 | PDF views : 0 |
Cite |
Full Text Download
|
References
Aryananda, R. A., Duvekot, J. J., Van Beekhuizen, H. J., Cininta, N. I., Ariani, G., & Dachlan, E. G. (2024). Transabdominal and transvaginal ultrasound findings help to guide the clinical management of placenta accreta spectrum cases. Acta Obstetricia et Gynecologica Scandinavica, 103(1), 93–102. https://doi.org/10.1111/aogs.14715
Badan Pusat Statistik. (2024). Profil Kesehatan Ibu dan Anak 2024 (Vol. 10).
Beigi, R., Phillips Heine, ; R, Silver, R. M., & Wax, J. R. (2012). Placenta Accreta Spectrum.
Biondi, C., Ferretti, M. E., Pavan, B., Lunghi, L., Gravina, B., Nicoloso, M. S., Vesce, F., & Baldassarre, G. (2006). Prostaglandin E2 Inhibits Proliferation and Migration of HTR-8/SVneo Cells, a Human Trophoblast-derived Cell Line. Placenta, 27(6–7), 592–601. https://doi.org/10.1016/j.placenta.2005.07.009
Braithwaite, S., & Jarabak, J. (1975). Studies on a 15-hydroxyprostaglandin dehydrogenase from human placenta. Purification and partial characterization. Journal of Biological Chemistry, 250(6), 2315–2318. https://doi.org/10.1016/S0021-9258(19)41718-3
Ensor, C. M., Yang, J. Y., Okita, R. T., & Tai, H. H. (1990). Cloning and sequence analysis of the cDNA for human placental NAD+-dependent 15-hydroxyprostaglandin dehydrogenase. Journal of Biological Chemistry, 265(25), 14888–14891. https://doi.org/10.1016/s0021-9258(18)77199-8
Erwich, J. J. H. M., & Keirse, M. J. N. C. (1988). Human placental 15-hydroxy-prostaglandin dehydrogenase activity is under fetal genetic control. Prostaglandins, 35(1), 123–131. https://doi.org/10.1016/0090-6980(88)90280-8
Huang, N., Liu, B., Dong, Z., Mao, W., Zhang, N., Li, C., & Cao, J. (2015). Prostanoid receptors EP2, EP4, and FP are regulated by estradiol in bovine oviductal smooth muscle. Prostaglandins and Other Lipid Mediators, 121, 207–217. https://doi.org/10.1016/j.prostaglandins.2015.08.002
Jauniaux, E., Bunce, C., Grønbeck, L., & Langhoff-Roos, J. (2019). Prevalence and main outcomes of placenta accreta spectrum: a systematic review and meta-analysis. American Journal of Obstetrics and Gynecology, 221(3), 208–218. https://doi.org/10.1016/j.ajog.2019.01.233
Jauniaux, E., Collins, S., & Burton, G. J. (2018). Placenta accreta spectrum: pathophysiology and evidence-based anatomy for prenatal ultrasound imaging. American Journal of Obstetrics and Gynecology, 218(1), 75–87. https://doi.org/10.1016/j.ajog.2017.05.067
Kandola, M. K., Sykes, L., Lee, Y. S., Johnson, M. R., Hanyaloglu, A. C., & Bennett, P. R. (2014). EP2 receptor activates dual g protein signaling pathways that mediate contrasting proinflammatory and relaxatory responses in term pregnant human myometrium. Endocrinology, 155(2), 605–617. https://doi.org/10.1210/en.2013-1761
Kim, S.-M., & Kim, J.-S. (2017). A Review of Mechanisms of Implantation. Development & Reproduction, 21(4), 351–359. https://doi.org/10.12717/DR.2017.21.4.351
Krook, M., Marekov, L., & Jörnvall, H. (1990). Purification and structural characterization of placental NAD+-linked 15-hydroxyprostaglandin dehydrogenase. The primary structure reveals the enzyme to belong to the short-chain alcohol dehydrogenase family. Biochemistry, 29(3), 738–743. https://doi.org/10.1021/bi00455a021
Lennon, C., Carlsona, M. G., Nelson, D. M., & Sadovsky, Y. (1999). In vitro modulation of the expression of 15-hydroxy-prostaglandin dehydrogenase by trophoblast differentiation. American Journal of Obstetrics and Gynecology, 180(3), 690–695. https://doi.org/10.1016/S0002-9378(99)70274-7
Li, Y., He, P., Sun, Q., Liu, J., Gao, L., You, X., Gu, H., & Ni, X. (2013). Reduced Expression of 15-Hydroxy Prostaglandin Dehydrogenase in Chorion during Labor Is Associated with Decreased PRB and Increased PRA and GR Expression. The American Journal of Pathology, 182(5), 1585–1594. https://doi.org/10.1016/j.ajpath.2013.01.033
Marcellin, L., Delorme, P., Bonnet, M. P., Grange, G., Kayem, G., Tsatsaris, V., & Goffinet, F. (2018). Placenta percreta is associated with more frequent severe maternal morbidity than placenta accreta. American Journal of Obstetrics and Gynecology, 219(2), 193.e1-193.e9. https://doi.org/10.1016/j.ajog.2018.04.049
Mirani, P., Lestari, P. M., Murti, K., Liberty, I. A., Andrina, H., Kesty, C., & Stevanny, B. (2023). Placenta accreta spectrum disorder: An updated literature review. Jurnal Kedokteran Dan Kesehatan Indonesia. https://doi.org/10.20885/jkki.vol14.iss3.art15
Morlando, M., Sarno, L., Napolitano, R., Capone, A., Tessitore, G., Maruotti, G. M., & Martinelli, P. (2013). Placenta accreta: incidence and risk factors in an area with a particularly high rate of cesarean section. Acta Obstetricia et Gynecologica Scandinavica, 92(4), 457–460. https://doi.org/10.1111/aogs.12080
Nagai, K., Nabekura, H., Mibe, M., Ohshige, T., & Mori, N. (1991). Prostaglandin dehydrogenase activity in placenta and in maternal lung, kidney, and gastric mucosa during rat pregnancy. Molecular and Cellular Endocrinology, 80(1–3), 153–163. https://doi.org/10.1016/0303-7207(91)90152-I
Norwitz, E. R. (2006). Defective implantation and placentation: laying the blueprint for pregnancy complications. Reproductive BioMedicine Online, 13(4), 591–599. https://doi.org/10.1016/S1472-6483(10)60649-9
Okita, R. T., & Okita, J. R. (1996). Prostaglandin-metabolizing enzymes during pregnancy: Characterization of NAD+-dependent prostaglandin dehydrogenase, carbonyl reductase, and cytochrome P450-dependent prostaglandin omega-hydroxylase. In Critical Reviews in Biochemistry and Molecular Biology (Vol. 31, Number 2, pp. 101–126). Informa Healthcare. https://doi.org/10.3109/10409239609106581
Patel, F. A., Funder, J. W., & Challis, J. R. G. (2003). Mechanism of Cortisol/Progesterone Antagonism in the Regulation of 15-Hydroxyprostaglandin Dehydrogenase Activity and Messenger Ribonucleic Acid Levels in Human Chorion and Placental Trophoblast Cells at Term. The Journal of Clinical Endocrinology & Metabolism, 88(6), 2922–2933. https://doi.org/10.1210/jc.2002-021710
Peng, L., Chelariu-raicu, A., Ye, Y., Ma, Z., Yang, H., Ishikawa-ankerhold, H., Rahmeh, M., Mahner, S., Jeschke, U., & von Schönfeldt, V. (2021). Prostaglandin E2 receptor 4 (EP4) affects trophoblast functions via activating the cAMP-PKA-pCREB signaling pathway at the maternal–fetal interface in unexplained recurrent miscarriage. International Journal of Molecular Sciences, 22(17). https://doi.org/10.3390/ijms22179134
Phillips, R. J., Fortier, M. A., & López Bernal, A. (2014). Prostaglandin pathway gene expression in human placenta, amnion and choriodecidua is differentially affected by preterm and term labour and by uterine inflammation. BMC Pregnancy and Childbirth, 14(1). https://doi.org/10.1186/1471-2393-14-241
Popovici, R. M., Betzler, N. K., Krause, M. S., Luo, M., Jauckus, J., Germeyer, A., Bloethner, S., Schlotterer, A., Kumar, R., Strowitzki, T., & Von Wolff, M. (2006). Gene expression profiling of human endometrial-trophoblast interaction in a coculture model. Endocrinology, 147(12), 5662–5675. https://doi.org/10.1210/en.2006-0916
Rahmi, J., Noviana Sari, Y., Aprilianingrum, L., Sri Muzdalifah, R., Assa, A., Kusoemo, diah, Tinggi Ilmu Kesehatan Widya Dharma Husada Tangerag, S., No, J., Barat, P., Pamulang, K., & Tangerang Selatan, K. (2025). Deteksi Dini Faktor Resiko Dan Intervensi Melalui Pelayanan Anc Untuk Mencegah Terjadinya Kekurangan Energi Kronis (Kek) Early Detection Of Risk Factors And Intervention Through Antenatal Care (Anc) To Prevent Chronic Energy Deficiency (Ced). In Jurnal Abdi Masyarakat (Vol. 6, Number 1).
Roizen, J. D., Asada, M., Tong, M., Tai, H. H., & Muglia, L. J. (2019). Early pregnancy loss in 15-hydroxyprostaglandin dehydrogenase knockout (15-HPGD−/−) mice due to requirement for embryo 15-HPGD activity. Scientific Reports, 9(1). https://doi.org/10.1038/s41598-019-54064-7
Simmons, D. L., Botting, R. M., & Hla, T. (2004). Cyclooxygenase Isozymes: The Biology of Prostaglandin Synthesis and Inhibition. Pharmacological Reviews, 56(3), 387–437. https://doi.org/10.1124/pr.56.3.3
Stadtmauer, D. J., & Wagner, G. P. (2022). Single-cell analysis of prostaglandin E2-induced human decidual cell in vitro differentiation: a minimal ancestral deciduogenic signal. Biology of Reproduction, 106(1), 155–172. https://doi.org/10.1093/biolre/ioab183
Tamura, K., Sakurai, T., & Kogo, H. (2006). Relationship between prostaglandin E2 and vascular endothelial growth factor (VEGF) in angiogenesis in human vascular endothelial cells. Vascular Pharmacology, 44(6), 411–416. https://doi.org/10.1016/j.vph.2006.02.009
von Hof, J., Sprekeler, N., Schuler, G., Boos, A., & Kowalewski, M. P. (2017). Uterine and placental expression of HPGD in cows during pregnancy and release of fetal membranes. Prostaglandins and Other Lipid Mediators, 128–129, 17–26. https://doi.org/10.1016/j.prostaglandins.2016.12.003
Ye, Y., Lin, P., Zhu, J., Jeschke, U., & von Schönfeldt, V. (2020). Multiple Roles of Prostaglandin E2 Receptors in Female Reproduction †. Endocrines, 1(1), 22–34. https://doi.org/10.3390/endocrines1010003
Ye, Y., Vattai, A., Ditsch, N., Kuhn, C., Rahmeh, M., Mahner, S., Ripphahn, M., Immler, R., Sperandio, M., Jeschke, U., & Von Schönfeldt, V. (2018). Prostaglandin E2 receptor 3 signaling is induced in placentas with unexplained recurrent pregnancy losses. Endocrine Connections, 7(5), 749–761. https://doi.org/10.1530/EC-18-0106
Yifru Berhan, & Tadesse Urgie. (2020). A Literature Review of Placenta Accreta Spectrum Disorder: The Place of Expectant Management in Ethiopian Setup. Ethiopian Journal of Health Sciences, 30(2). https://doi.org/10.4314/ejhs.v30i2.16
Young, I. R., & Thorburn, G. D. (1994). Prostaglandin E 2 , Fetal Maturation and Ovine Parturition. Australian and New Zealand Journal of Obstetrics and Gynaecology, 34(3), 342–346. https://doi.org/10.1111/j.1479-828X.1994.tb01086.x
Refbacks
- There are currently no refbacks.
Copyright (c) 2026 Tin Elasari*, Krisna Murti, Erry Gumilar Dachlan, Iche Andriyani Liberty, Rozi Aditya Aryananda
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Electronic Journal of Education, Social Economics and Technology (eJESET)
ISSN 2723-6250 (Online)
Published by the SAINTIS Publishing
Homepage: http://ejeset.saintispub.com
Editor E-mail : ; editor.ejeset@gmail.com
Editorial Office Address:
